par Negueruela Escudero, Javier
;Vandenbempt, Valerie
;Talamantes, Stephanie
;Ribeiro-Costa, Francisco;Nunes, Mariana;Marques Dias, André
;Bansal, Mayank
;Gurzov, Esteban Nicolas 
Référence STAR Protocols, 5, 3, page (103297)
Publication Publié, 2024-09-01






Référence STAR Protocols, 5, 3, page (103297)
Publication Publié, 2024-09-01
Article révisé par les pairs
Résumé : | Gene editing of human pluripotent stem cells is a promising approach for developing targeted gene therapies for metabolic diseases. Here, we present a protocol for generating a CRISPR-Cas12a gene knockout of protein tyrosine phosphatases in human embryonic stem cells. We describe steps for differentiating the edited clones into pancreatic islet-like spheroids rich in β-like cells. We then detail procedures for implanting these spheroids under the murine kidney capsule for in vivo maturation. |